SAN RAFAEL, Calif.,
Jan. 23, 2019 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced
that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of
BioMarin, will host a conference call and webcast on Thursday, February 21, at 4:30 p.m. ET to discuss fourth quarter and full
year 2018 financial results and provide a general business
update.
Dial-in Number
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 8265006
Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 8265006
Interested parties may access a live audio webcast of the
conference call via the investor section of the BioMarin
website, www.biomarin.com. A replay of the call
will be archived on the site for one week following the call.
About BioMarin
BioMarin is a global biotechnology
company that develops and commercializes innovative therapies for
patients with serious and life-threatening rare and ultra-rare
genetic diseases. The company's portfolio consists of seven
commercialized products and multiple clinical and pre-clinical
product candidates. For additional information, please
visit www.biomarin.com.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Debra
Charlesworth
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2018-financial-results-conference-call-and-webcast-on-thursday-february-21-at-430pm-et-300782577.html
SOURCE BioMarin Pharmaceutical Inc.